In short. Sun protection has almost no downside and treatments do. Doing less is often the higher-value long-term plan, and doing nothing is sometimes the honest one.
Key points
- Daily sun protection, not smoking, and a topical retinoid if the skin tolerates it.
- That short list is supported by longer-running evidence than anything else in the field, and it does not require a device, a course or a supplement.
- A person doing those three things and nothing else is doing more, in evidence terms, than a person buying into the category.
The risks in this subject are asymmetric in a way that is genuinely unusual, and the asymmetry is the most useful thing that can be said about it. Sun protection has almost no downside. Everything else in the category has some.
The interventions, and what they cost
Topical retinoids cause irritation and photosensitivity, particularly in the first weeks, and they require continued use for the effect to persist. Devices carry burn, pigment change and scarring, and they treat damage that is present rather than the process behind it, which means a treated finding can recur while both underlying processes continue. Supplements and drinks carry the cost of the product and, in some cases, of displacing attention from what has evidence. Sun protection carries almost nothing: it is cheap, it is supported by the strongest evidence in the field, and its main failure mode is that people do not use enough of it consistently enough.
The larger risk
The larger risk is not a treatment risk. It is the risk of spending years on a category rather than on a finding, buying substances and programmes whose evidence is a mechanism while the one intervention with substantial support is applied occasionally. This is the failure mode the category is designed to produce, because the marketed options are numerous, pleasant to use and sold as longevity, and the effective one is unglamorous and free at the point of use.
The best-supported plan is also the cheapest
Daily sun protection, not smoking, and a topical retinoid if the skin tolerates it. That short list is supported by longer-running evidence than anything else in the field, and it does not require a device, a course or a supplement. A person doing those three things and nothing else is doing more, in evidence terms, than a person buying into the category.
The alternatives
Doing less is the alternative that is supported best and described last. Doing nothing is reasonable where no specific finding has appeared, because ageing in general cannot be measured and a plan organised around it cannot be judged. Where a named finding appears, treating it on its own terms is a better-defined proposition than treating a category, and the device and injectable guides in this cluster describe those options and their evidence position. Which applies is an individual clinical question, and this review does not answer it for anyone.
When to have something looked at rather than treated
- A mole or patch that is changing in size, shape or colour.
- A lesion that bleeds, itches or will not heal.
- Blistering, crusting or pigment change that follows a device treatment.
None of those is a longevity question, and all three are reasons to see a clinician rather than to buy anything.
Frequently asked questions
What are the risks of the treatments sold for skin longevity?
Topical retinoids cause irritation and photosensitivity, particularly in the first weeks. Devices carry burn, pigment change and scarring, and they treat damage that is present rather than the process behind it. The larger risk is spending years and money on the category while the one intervention with substantial evidence is used inconsistently.
Does sun protection have any downside?
Almost none, and it is worth stating because it is the only intervention in the field with that profile. It is cheap, it is supported by long-running population studies, and its main failure mode is inconsistent use. The one practical caution is that protection should not be so complete that vitamin D status is affected, which is a question for a clinician rather than a reason to skip it.
Is doing less a reasonable plan?
For a person with no named finding, it is the best-supported plan available. Sun protection, not smoking and a topical retinoid if the skin tolerates it is a short list with long-running evidence behind it, and it does not require a device, a course of treatment or a supplement. Where a specific finding appears, it can be assessed on its own terms.
Risks & Limitations
- Sun protection has the strongest evidence in the field and almost no downside; almost nothing else in the category does.
- Nothing is approved as a treatment for skin ageing itself, and approvals belong to products and defined endpoints.
- Topical retinoids irritate and require continued use; devices carry burn, pigment change and scarring.
- Supplements, drinks and programmes sold as longevity have no demonstrated effect on how skin ages in people.
- A mechanism is a reason to study something rather than a result, and a treated finding can recur.
When to Seek Care
- A mole or patch that is changing in size, shape or colour — have it assessed by a clinician.
- A lesion that bleeds, itches or will not heal — have it assessed by a clinician.
- Blistering, crusting or pigment change that follows a device treatment — have it assessed by a clinician.
- A rash, or irritation from a topical that does not settle when use is paused, is assessed by a clinician rather than managed indefinitely.
References & Further Reading
- World Health Organization (WHO) — ultraviolet radiation and skin cancer prevention guidance
- U.S. Food and Drug Administration (FDA) — sunscreen and topical product labelling and indications
- National Medical Products Administration (NMPA, China) — approved products and their indications
- Cochrane Library — systematic reviews of topical treatments and photoprotection
- Chinese Medical Association Dermatology Branch — clinical guidance
This page is a review of published evidence and regulation, not medical advice, and it does not cite individual studies. It is not a booking page and it does not recommend a product or treatment. Discuss your own case with a qualified clinician. To ask a question about this review, see Contact & Consultation.